Medical Facilities Corporation
TSX:DR.TOMedical - Care Facilities
+$0.18 today
- Market cap
- $282.59M
- Beta
- 0.34
- P/E (TTM)
- 8.7
- EPS (TTM)
- $1.47
- Dividend yield
- 2.00%
Volume 0.04M
Average 0.02M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Medical Facilities Corporation
TSX:DR.TO
Intrinsic Alpha fair value
Locked
Current Price
$17.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +37.4% | +18.7% (3yr)1 analysts |
| Revenue | N/A | N/A | -15.2% | +2.2% (3yr)1 analysts |
| Net Income | N/A | N/A | N/A | +19.0% (3yr)1 analysts |
| EBIT | N/A | N/A | +10.8% | +5.4% (3yr)1 analysts |
Analysis
Recent growth has been strongest in EPS at +37.4% over three years. Forward estimates point to Net Income at +19.0% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Eupraxia Pharmaceuticals Inc. TSX:EPRX.TO | $783.37M | $11.65 | Not rated | -8.6 | +0.80% |
Fennec Pharmaceuticals Inc. TSX:FRX.TO | $580.71M | $16.56 | Not rated | -36.5 | +58.04% |
Profound Medical Corp. TSX:PRN.TO | $388.24M | $10.60 | Not rated | -6.3 | +16.06% |
Auxly Cannabis Group Inc. TSX:XLY.TO | $365.45M | $3.54 | Overvalued | 7.3 | +2334.48% |
Canopy Growth Corporation TSX:WEED.TO | $364.19M | $0.81 | Not rated | -1.8 | -51.35% |
CareRx Corporation TSX:CRRX.TO | $204.24M | $3.22 | Undervalued | 7.4 | -4.18% |
TerrAscend Corp. TSX:TSND.TO | $201.10M | $0.54 | Not rated | -2.5 | -1.89% |
OrganiGram Holdings Inc. TSX:OGI.TO | $166.39M | $1.18 | Not rated | -7.2 | -54.72% |
Continue the stock analysis
Jump to another research area for this company.